Grid of ribbon diagrams of designed protein structures, several bound to small molecules or to DNA and RNA helices

NVIDIA exec on how AI helped David Baker’s lab design a pesticide-degrading enzyme

Marcel Frenkel, co-founder and CEO of Ten63 Therapeutics

Chugai joins Ten63’s bid to simulate the data that ‘undruggable’ targets lack

OpenAI’s GPT-6.2 Astra trails Claude Fable 5.2 by three points on an independent AI index at a fraction of the cost per task

Isomorphic Labs illustration of translucent pink molecular surfaces around a green double helix against a peach background

Isomorphic Labs raises $5 billion in biotech’s biggest venture round

QuEra exec on AI-designed quantum circuits, and why he doesn’t expect drug discovery to be quantum’s first big win

Clipboard, woman and scientist writing in laboratory for medical research on cancer drug trial. Checklist, investigation and female biologist with clinic protocol development for pharmaceutical study.

Pharma is pouring billions into AI. The biggest returns may take years to prove.

How Fermilab plans to fill two giant underground tanks with 34,000 tons of liquid argon

As AI bubble talk grows, Dwarkesh Patel predicts recursive self-improvement will set off an AI research explosion

Bar chart of NVIDIA's quarterly research and development expense, rising from $2.7 billion in the first quarter of fiscal 2025 to $3.7 billion in the fourth, $5.5 billion in the fourth quarter of fiscal 2026 and $7.1 billion in the second quarter of fiscal 2027

NVIDIA’s R&D spending more than doubled in two years. Its customers’ borrowing will help decide what happens next.